Journal
JOURNAL OF SURGICAL ONCOLOGY
Volume 108, Issue 1, Pages 14-18Publisher
WILEY-BLACKWELL
DOI: 10.1002/jso.23352
Keywords
carcinoembryonic antigen; colon cancer; prognosis; confounders; outcomes
Funding
- Fulbright Foundation
- Harvard Catalyst \ The Harvard Clinical and Translational Science Center
- Dutch Cancer Society
- Dutch Digestive Society
- Amsterdam University
Ask authors/readers for more resources
Objective Several reports have shown that certain pre-operative CEA intervals can be predictive of long-term outcomes and have subsequently implied that preoperative CEA may be useful to assess the risk of recurrence or death as a continuous number for individual cases. This analysis assesses if this hypothesis is valid after correction for confounders. Methods All colon cancer patients operated on at Massachusetts General Hospital from 2004 through 2011 were considered for retrospective review. Association between outcomes and preoperative CEA was measured in intervals and as a linear relationship. Results Of the 1,071 patients operated for colon adenocarcinoma, 621 (57.9%) had a preoperative CEA drawn and were included in the analysis. In models using intervals, preoperative CEA did show association with (disease-free) survival, but this was shown to be chiefly a surrogate for metastatic presentation. In linear approaches adjusted for metastatic presentation, CEA loses all correlations with metastatic disease (P=0.84), survival (P=0.11), survival duration (P=0.42) and disease-free interval (P=0.94). Conclusions Extrapolating the predictive value of certain preoperative CEA intervals to a continuous approach for use in a case-for-case basis is unjustified. Preoperative CEA may be a useful risk estimator but has limited significance for predictions of long-term outcomes in individual cases. J. Surg. Oncol. 2013;108:14-18. (c) 2013 Wiley Periodicals, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available